<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Crestor and Other Statins: Are They Really Worth the Risk?</title><link>http://articles.mercola.com/sites/articles/archive/2003/11/08/crestor-statins.aspx</link><description>By Dr. Joseph Mercola with Rachael Droege With at least 12 million Americans taking cholesterol-lowering drugs, mostly statins, and experts’ recommendations that another 23 million should be taking them, it’s no wonder that the drug companies are scrambling</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>